News
There is an unmet need for safe, effective, long-term therapies for autoimmune disorders. NIH inventors have isolated a population of mammalian cells comprising about 75% or higher B-1a regulatory cells (Bregs) and methods of preparation of such cell populations as a therapeutic for immune-related
The NCI Technology Transfer Center (TTC) is seeking qualified candidates for the position of Associate Director. Qualified applicants will be able to apply Dec 11 - 15, 2023. The duties of the TTC Associate Director include: Directing work through subordinate supervisors and team leads. Providing
The Licensing Executives Society (LES) is hosting a webinar featuring the National Cancer Institute’s (NCI) Andy Burke discussing Yescarta’s® journey from development to licensing. The presentation will address two topics related to licensing efforts of NCI. The first, a case study on the CAR-T
Register to attend a free NIH webinar featuring a licensing opportunity for a first-of-its-kind male contraceptive hormonal gel, Nestorone®/Testosterone (NES/T), co-developed by the NICHD and Population Council through the Contraceptive Clinical Trials Network (CCTN). This topical, daily self